FINNENCE ▪ THE WIRE FILE
THE WIRE · № 77401
News▼ Bearish
125,000 restricted shares accompany FibroBiologics (FBLG)'s convertible debt offering.
KINDNews
DIRECTION▼ Bearish
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN
LAST UPDATE
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Restricted shares tied to a convertible offering signal dilution and financing need for a small biotech.
Small-cap biotech funds itself with dilution
CATALYST TO WATCH
Terms and pricing of the offering
MAIN RISK
Further dilution if cash burn persists
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
Kelun-Biotech to Present Multiple Study Results at ESMO 20262026-10-13 11:18 UTC
Kelun-Biotech to Present Multiple Study Results at ESMO 20262026-10-13 11:18 UTC
→CORRELATIONshares Healthcare
GCCL y LabConnect amplían la colaboración en ensayos clínicos a nivel mundial2026-10-13 11:21 UTC
GCCL y LabConnect amplían la colaboración en ensayos clínicos a nivel mundial2026-10-13 11:21 UTC
→CORRELATIONshares Healthcare
ZIMMER BIOMET AND THINK SURGICAL EXTEND EXCLUSIVE DISTRIBUTION AGREEMENT2026-10-13 11:30 UTC
ZIMMER BIOMET AND THINK SURGICAL EXTEND EXCLUSIVE DISTRIBUTION AGREEMENT2026-10-13 11:30 UTC
→CORRELATIONshares Healthcare
Vector Science and Therapeutics Corp. Announces Collaboration and SAFE Investment in Whoopi Wellness, Inc.2026-10-13 11:30 UTC
Vector Science and Therapeutics Corp. Announces Collaboration and SAFE Investment in Whoopi Wellness, Inc.2026-10-13 11:30 UTC
→CORRELATIONshares Healthcare
Health Care Spending for People with Employer-Sponsored Insurance Reached $6,743 Per Person in 20232026-10-13 11:32 UTC
Health Care Spending for People with Employer-Sponsored Insurance Reached $6,743 Per Person in 20232026-10-13 11:32 UTC
→CORRELATIONshares Healthcare
Semaglutide-treated aged mice lost late-life lean mass. Pulmatrix (PULM) shares a PTC-2105 comparison.2026-10-13 11:12 UTC
Semaglutide-treated aged mice lost late-life lean mass. Pulmatrix (PULM) shares a PTC-2105 comparison.2026-10-13 11:12 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.